Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on aTyr Pharma (ATYR – Research Report) today and set a price target of $20.00. The company’s shares closed yesterday at $3.99.

While modern society’s relationship with mental health as evolved in recent decades, pharmaceutical innovation has yet to keep pace, mostly due ...

Eye surgery specialist BVI Medical announced this week it has raised $1 billion in new financing as it looks to boost its global intraocular lens business with “several new product launch | BVI said ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 ...

Honda Motor Company confirmed it plans to cut its engine production capacity in China, as it grapples with rising overcapacity due to intensifying competition from local manufacturers and falling ...

Produce high-quality, injectable drug delivery systems with the Thermo Scientific™ Pharma mini Implant Line. This automated end-to-end solution meets cGMP and FDA requirements. Accurate dosing ...